Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
alzheimer's disease
3
×
biotech
boston blog main
boston top stories
clinical trials
crispr
3
×
life sciences
national blog main
san francisco blog main
allergan
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
eli lilly
glaxosmithkline
indiana blog main
indiana top stories
merck
national
national top stories
new york blog main
new york top stories
parkinson's disease
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acceleron pharma
What
bio
companies
roundup
abbvie
alliance
approval
biogen’s
biopharmaceutical
biotech
black
continue
convo
debut
diamond
diamond’s
drug
earlier
editas
editing
exits
experimental
failures
gene
genetic
indication
leading
life
littered
mammoth
march
medicines
moves
nash
new
news
ohana’s
pact
partnership
pop
price
Language
unset
Current search:
crispr
×
" alzheimer's disease "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
